S9 VPAPTM Adapt with PaceWaveTM Support

  • With ResMed, your patients won’t need to walk the therapy journey alone. We’re here to offer help and support along the way, so they can get the most out of their therapy.

    Item Code
    VPAP Adapt 36367
    S9 VPAPTM Adapt with PaceWaveTM Product Page

S9 VPAP Adapt Downloads

Documents

Reference

ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.